www.fdanews.com/articles/102524-genitope-reports-initial-results-of-myvax-trial
Genitope Reports Initial Results of MyVax Trial
December 21, 2007
Genitope Corporation announced that its pivotal Phase III clinical trial examining the use of MyVax personalized immunotherapy in previously untreated follicular B-cell non-Hodgkin’s lymphoma (fNHL) patients did not meet its primary endpoint.
Yahoo! Finance
Yahoo! Finance